secwatch.observer — SEC 8-K summary
======================================

Issuer:     Agentix Corp. (AGTX)
CIK:        0001603345
Form:       8-K
Filed at:   2021-07-14T23:59:59+00:00
Accession:  0001477932-21-004619
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agentix corrects prior filing; enters merger to make Applied BioPharma wholly-owned sub
--------------------------------------------------------------------------------

- Corrects May 27, 2021 8-K to clarify Applied BioPharma was not then a wholly-owned subsidiary.
- Enters Merger Agreement (July 13, 2021) with AB Merger LLC to acquire Applied BioPharma for 1 share of common stock.
- Articles of Merger executed July 14, 2021, expected to be filed with Nevada Secretary of State on July 15, 2021.
- Upon consummation, Applied BioPharma will become a wholly-owned subsidiary of Agentix Corp.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1603345/000147793221004619/0001477932-21-004619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1603345/000147793221004619/agtx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-21-004619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer